DXJ:NYE-WisdomTree Japan Hedged Equity Fund (USD)

ETF | Japan Stock |

Last Closing

USD 110.68

Change

+3.10 (+2.88)%

Market Cap

N/A

Volume

0.53M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

+0.31 (+1.03%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+1.88 (+2.59%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

+0.84 (+2.73%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

+0.73 (+0.92%)

N/A
EWJ iShares MSCI Japan ETF

+0.93 (+1.31%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

+0.56 (+1.42%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+1.10 (+2.64%)

N/A
JPXN iShares JPX-Nikkei 400 ETF

+0.88 (+1.16%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

+0.44 (+0.56%)

N/A

ETFs Containing DXJ

XNAV FundX Aggressive ETF 7.46 % 0.00 %

+1.00 (+1.48%)

N/A
GTAA 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.80% 100% F 86% B+
Dividend Return 1.09% 60% D- 21% F
Total Return 26.89% 100% F 85% B
Trailing 12 Months  
Capital Gain 28.29% 100% F 70% C-
Dividend Return 2.98% 80% B- 41% F
Total Return 31.27% 100% F 69% C-
Trailing 5 Years  
Capital Gain 122.70% 100% F 88% B+
Dividend Return 19.36% 70% C- 66% D+
Total Return 142.06% 100% F 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.65% N/A N/A 83% B
Dividend Return 23.81% N/A N/A 83% B
Total Return 3.16% N/A N/A 62% D
Risk Return Profile  
Volatility (Standard Deviation) 16.67% N/A N/A 60% D-
Risk Adjusted Return 142.81% N/A N/A 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike